期刊文献+

CARD10在乳腺癌中的表达及对细胞周期和增殖能力的影响 被引量:2

Expression of CARD10 in Breast Cancer and Its Effect on Cell Cycle and Proliferation
原文传递
导出
摘要 目的检测CARD10在乳腺癌组织中的表达情况及体外沉默其表达后对MDA-MB-231乳腺癌细胞周期、增殖能力的影响。方法利用免疫组织化学染色检测CARD10在62例乳腺癌及8例正常乳腺组织中的表达;利用化学合成的靶向CARD10-siRNA转染MDA-MB-231, 48 h后,RT-PCR检测干扰效率,流式细胞实验检测细胞周期变化,CCK-8检测增殖能力变化。结果CARD10在乳腺癌组织中显著性高表达,且与乳腺癌患者分期相关(P<0.05);CARD10被沉默后,抑制M DA-MB-231细胞增殖,阻滞细胞周期进程。结论CARD10促进乳腺癌MDA-MB-231细胞周期进程和细胞增殖,该研究为CARD10在乳腺癌的靶向治疗奠定了基础理论依据。 Objective This study examined the expression of CARD10 in breast cancer and the effect of silencing its expression in vitro on cell cycle and proliferation of MDA-MB-231 breast cancer cells. Methods The expression of CARD10 in 62 cases of breast cancer and 8 cases of normal breast tissue was detected by immunohistochemical staining. MDA-MB-231 was transfected with chemically synthesized targeted CARD10-siRNA. After 48 hours, interference efficiency was detected by RT-PCR, cell cycle was detected by flow cytometry, and proliferation ability was detected by CCK-8. Results The expression of CARD10 was significantly higher in breast cancer tissues and correlated with the stage of breast cancer (P <0. 05 ). After the silence of CARD10, the proliferation of MDA-MB-231 cells was inhibited and the cells were arrested in the cell cycle. Conclusion CARD10 promotes the cell cycle and proliferation of breast cancer MDA-MB-231. This study lays a theoretical foundation for the targeted treatment of breast cancer with CARD10.
作者 张艳平 李雪兰 丁矢 陈兴凤 ZHANG Yanping;LI Xuelan;DING Shi;CHEN Xingfen(Department of Clinical Medicine, Changde Vocational and Technical College, Changde, Hunan, 415000, China)
出处 《医学分子生物学杂志》 CAS 2019年第3期239-243,共5页 Journal of Medical Molecular Biology
基金 湖南省教育厅科研项目(No.16C0205).
关键词 CARD10 免疫组化 MDA-MB-23:细胞周期 CARD 10 immunohistochemistry MDA-MB-23 cell cycle
  • 相关文献

参考文献1

二级参考文献11

  • 1Early Breast Cancer Trialists' Collaborative G. Lancet 2005; 365:1687–1717.
  • 2Roop RP, Ma CX. Future Oncol 2012; 8:273–292.
  • 3Filippakopoulos P, Qi J, Picaud S, et al. Nature 2010; 468:1067–1073.
  • 4Dawson MA, Prinjha RK, Dittmann A, et al. Nature 2011; 478:529–533.
  • 5Feng Q, Zhang Z, Shea MJ, et al. Cell Res 2014; 24:809–819.
  • 6Asangani IA, Dommeti VL, Wang X, et al. Nature 2014; 510:278–282.
  • 7Mitsiades N. Cancer Res 2013; 73:4599–4605.
  • 8Lehmann BD, Bauer JA, Chen X, et al. J Clin Invest 2011; 121:2750–2767.
  • 9Shi J, Wang Y, Zeng L, et al. Cancer Cell 2014; 25:210–225.
  • 10French CA. Annu Rev Pathol 2012; 7:247–265.

同被引文献26

引证文献2

二级引证文献30

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部